Evidence Library
Filter by drug, type, year, and open access.
Showing 301–350 of 427 results
- Brexpiprazole in schizophrenia and major depressive disorder: evidence review — Clinical Schizophrenia & Related Psychoses (2016)• Drug: brexpiprazolePMID
- Olanzapine/fluoxetine for bipolar depression: randomized trials — RCTs (2016)• Drug: olanzapine
- Cariprazine in bipolar I depression: randomized controlled trial — American Journal of Psychiatry (2016)• Drug: cariprazineDOIPMID
- Therapeutic drug monitoring of clomipramine and desmethylclomipramine — Therapeutic Drug Monitoring (2016)• Drug: clomipramineDOI
- Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials — Biological Psychiatry (2016)• Drug: suvorexantDOIPMID
- Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis — Journal of Psychopharmacology (2016)• Drug: propranololDOI
- Gabapentin misuse, abuse and diversion: a systematic review — Addiction (2016)• Drug: gabapentinDOI
- Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial — Human Psychopharmacology (2016)• Drug: lisdexamfetaminePMID
- Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials — International Journal of Neuropsychopharmacology (2016)• Drug: risperidone-microspheresOpen accessDOIPMIDPMCID
- Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria — Addiction (2016)• Drug: naloxoneOpen accessDOIPMIDPMCID
- Alpha₂-adrenergic agonists for the management of opioid withdrawal — Cochrane Database of Systematic Reviews (2016)• Drug: lofexidineOpen accessDOIPMIDPMCID
- Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial — The Lancet (2016)• Drug: vareniclineDOIPMID
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) — New England Journal of Medicine (2016)• Drug: semaglutide-ozempicDOI
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) — New England Journal of Medicine (2016)• Drug: semaglutide-wegovyDOI
- Brexpiprazole for acute schizophrenia: 6-week randomized trial — Schizophrenia Research (2015)• Drug: brexpiprazoleDOIPMID
- Vortioxetine improves cognitive function in major depressive disorder (FOCUS study) — Neuropsychopharmacology (2015)• Drug: vortioxetineDOIPMID
- Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials — The Lancet (2015)• Drug: tasimelteonDOIPMID
- Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia: A Randomized Clinical Trial — JAMA Psychiatry (2015)• Drug: paliperidone-palmitateDOIPMID
- Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management — CNS Drugs (2015)• Drug: olanzapine-pamoateDOIPMID
- New restrictions to minimise the risks of effects on heart rhythm with hydroxyzine-containing medicines — European Medicines Agency (2015)• Drug: hydroxyzineOpen access
- Asenapine review, part II: clinical efficacy, safety and tolerability — Expert Opinion on Drug Safety (2014)• Drug: asenapineDOI
- Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia — CNS Drugs (2014)• Drug: loxapineDOIPMID
- Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis — JAMA (2014)• Drug: naltrexoneDOIPMID
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence — Cochrane Database of Systematic Reviews (2014)• Drug: buprenorphineOpen accessDOIPMIDPMCID
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence — Cochrane Database of Systematic Reviews (2014)• Drug: buprenorphine-naloxoneOpen accessDOIPMIDPMCID
- Community management of opioid overdose — World Health Organization (2014)• Drug: naloxoneOpen access
- Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis — JAMA (2014)• Drug: acamprosateDOIPMID
- Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis — PLOS ONE (2014)• Drug: disulfiramOpen accessDOIPMIDPMCID
- Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis — JAMA (2014)• Drug: disulfiramDOIPMID
- Evidence-based pharmacological treatment of anxiety disorders — Depression and Anxiety (2014)• Drug: hydroxyzineDOI
- Evidence-based pharmacological treatment of anxiety disorders — Depression and Anxiety (2014)• Drug: lorazepamDOI
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial — Lancet (2014)• Drug: pimavanserinPMID
- Desvenlafaxine versus placebo in major depressive disorder — BMC Psychiatry (2013)• Drug: desvenlafaxineOpen accessDOIPMCID
- Randomized, double-blind trial of guanfacine extended release in children with ADHD: morning or evening administration — Journal of the American Academy of Child and Adolescent Psychiatry (2013)• Drug: guanfacine-erPMID
- Meta-analysis: melatonin for the treatment of primary sleep disorders — PloS one (2013)• Drug: melatoninOpen accessDOIPMIDPMCID
- Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials — Journal of Clinical Psychiatry (2013)• Drug: modafinilDOI
- Pitolisant versus placebo or modafinil in patients with narcolepsy — Lancet Neurology (2013)• Drug: pitolisantDOIPMID
- Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole — Current Medical Research and Opinion (2013)• Drug: aripiprazole-monohydrateDOIPMID
- Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis — BMJ (2013)• Drug: naloxoneOpen accessDOIPMIDPMCID
- FDA safety communication on citalopram dosing and QT prolongation — FDA Drug Safety Communication (2012)• Drug: citalopramOpen access
- Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care — International Journal of Psychiatry in Clinical Practice (2012)• Drug: clorazepateDOI
- First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness — AHRQ Comparative Effectiveness Review (NCBI Bookshelf) (2012)• Drug: chlorpromazineOpen access
- First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness — AHRQ Comparative Effectiveness Review (NCBI Bookshelf) (2012)• Drug: thiothixeneOpen access
- First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness — AHRQ Comparative Effectiveness Review (NCBI Bookshelf) (2012)• Drug: trifluoperazineOpen access
- First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness — AHRQ Comparative Effectiveness Review (NCBI Bookshelf) (2012)• Drug: thioridazineOpen access
- Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study — Current Medical Research and Opinion (2012)• Drug: gabapentin-enacarbilDOI
- Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care — International Journal of Psychiatry in Clinical Practice (2012)• Drug: hydroxyzineDOI
- Doxepin 3 and 6 mg for chronic primary insomnia — Sleep (2011)• Drug: doxepinDOI
- A Meta-Analysis of the Efficacy of Pregabalin in the Treatment of Generalized Anxiety Disorder — The Canadian Journal of Psychiatry (2011)• Drug: pregabalinDOI
- Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD — Pediatrics (2011)• Drug: clonidine-erPMID